Skip to main content
General Sense logo

General Sense

Alachua, Florida

  • Brain-computer interfaces
  • Seed

General Sense develops neural-decoding technology that digitizes dogs’ sense of smell to detect chemical signatures. Its platform combines neural interfaces, edge-based analysis, and fleet-wide learning to support applications in security, agriculture, and health.

Raised
$4M
Jan 2026
Seed
Investors
10
Employees
11–50

reccy insights

Recent highlights

General Sense’s most concrete public milestones center on funding and research rather than a documented product launch. On July 1, 2022, the company completed a $4 million seed round led by Breakout Ventures, with participation from investors including Dolby Family Ventures, KdT Ventures, and SOSV. On March 7, 2024, a published announcement reported that a Canaery-led research team received support through the U.S. National Science Foundation Convergence Accelerator. General Sense also has a seed round dated January 6, 2026, with NYU Innovation Venture Fund and SOSV named among the investors; no amount or lead investor is specified. The company’s stated focus is turning canine olfactory signals into digital detection information, including for identifying dangerous compounds. Gabriel Lavella is identified as CEO and founder.

Written by reccy's AI from company sites, press and funding records · updated Nov 2026

What makes General Sense distinct

  1. 01Reports detection of target compounds below 1 part per trillion and 96% accuracy across 24 compounds in controlled trials.
  2. 02Uses neural decoding to turn canine olfactory signals into objective digital detection readouts.
  3. 03Describes a federated learning system that shares chemical signatures across deployed dogs.
  4. 04Designed for offline operation, with neural decoding performed at the edge.
  5. 05States animal-welfare commitments that include retirement and adoption plans for dogs.

Technology & products

  • Nose-Computer Interface (NCI)

    A neural implant system that decodes scent information from animals' olfactory signals to identify dangerous compounds.

  • Neural olfactory decoding using a neural interface and surface electrodes.
  • Federated learning for sharing chemical signatures across a deployed dog fleet.
  • Edge inference for offline neural decoding.
  • Vaporware OS for geo- and time-stamped detection data, live readouts, and predictive analytics.

Funding

$4M disclosed
  • SeedJan 2026
  • SeedJul 2023
    DeepWork Capital
  • SeedJul 2022
10 investors

Similar companies

About General Sense

Products
Nose-Computer Interface (NCI)
Leadership
Gabriel Lavella, CEO & Founder
Focus areas
Artificial Intelligence (AI), data and analytics, information technology, software, NeuroTechnology, biotech, diagnostics, research tools
Headquarters
Alachua, Florida
Employees
11–50